Cytokinetics, IncorporatedCYTKNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank43
Year-over-Year Change

Price-to-earnings ratio

Latest
-9.72
↓ 82% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
-5.33
Historical baseline
PeriodValueYoY Change
2025-9.72-8.7%
2024-8.94+41.7%
2023-15.31-44.7%
2022-10.58+35.0%
2021-16.28-54.5%
2020-10.53-109.8%
2019-5.02-55.1%
2018-3.24-2.7%
2017-3.15-110.7%
201629.50-